Ciprofloxacin for treating urethral gonorrhoea in men.
AUTOR(ES)
Shahmanesh, M
RESUMO
The effectiveness of a single oral dose of ciprofloxacin in eradicating urethral gonorrhoea was assessed in 18 men who received 250 mg and 26 men who were given 100 mg. All patients, including two infected with beta lactamase (penicillinase) producing strains of Neisseria gonorrhoeae (PPNG), were cured. The drug had no effect on infection with Chlamydia trachomatis or on the incidence of post gonococcal urethritis. Ciprofloxacin may be useful in patients hypersensitive to penicillins and cephalosporins, and the drug may also be useful in urethral gonorrhoea caused by PPNG strains.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1011905Documentos Relacionados
- Asymptomatic urethral gonorrhoea in men.
- Single dose ciprofloxacin for treating gonococcal infections in men.
- Three regimens of procaine penicillin G, Augmentin, and probenecid compared for treating acute gonorrhoea in men.
- Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men.
- Neutrophil enzymes in urine for the detection of urethral infection in men.